使用机器学习模型对心脏性休克的动态评估是否会改善存活率?
Vishal Goel1, William Chan2, Jack Tan3
1Monash Victorian Heart Institute, Monash University, Clayton, Vic, Australia; School of Public Health and Preventive Medicine, Monash University, Melbourne, Vic, Australia. Electronic address: https://twitter.com/_VGoel.
Heart, lung & circulation
|November 6, 2025
概括
及时诊断心脏性休克 (CS) 对于改善存活率至关重要. 人工智能 (AI) 为CS患者的早期检测和干预提供了一个有希望的方法.
科学领域:
- 心脏病学 心脏病学
- 医疗信息学 医疗信息学
- 人工智能的人工智能
背景情况:
- 心脏性休克 (CS) 是急性心肌梗塞 (AMI) 的严重并发症,死亡率高.
- 目前的机械循环支持 (MCS) 并没有持续改善生存率,突出显示诊断延迟.
- 在可逆阶段识别CS对于有效干预至关重要.
研究的目的:
- 审查CS的病理生理学和当前诊断方法的局限性.
- 探索进行CS干预临床试验的挑战.
- 调查AI在早期CS诊断和干预方面的潜力.
主要方法:
- 文献综述侧重于CS病理生理学,诊断和治疗.
- 分析当前的诊断方法及其局限性.
- 在急性护理和决策支持系统中探索AI应用.
主要成果:
- 由于其异质性和依赖复杂的血液动力学和生物标志物解释,CS诊断往往会延迟.
- 由人工智能驱动的决策支持系统显示出早期检测患者病情恶化的潜力.
- 集成的人工智能系统可以动态表型患者,并支持临床决策.
结论:
- 早期和准确的CS诊断对于减少死亡率至关重要.
- 基于人工智能的方法对改善CS的及时诊断和管理具有重大前景.
- 对集成人工智能系统的进一步研究可以改善临床实践和患者的治疗结果.
相关概念视频
Cardiomyopathy II: Dilated Cardiomyopathy
451
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
451
Cardiomyopathy V: Interprofessional Care
323
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
323
Heart Failure IV: Classification and Diagnostic Evaluation
305
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
305
Cardiopulmonary Resuscitation IV: Pharmacological Management
623
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
623
Cardiopulmonary Resuscitation III: AED Use
502
Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
502


